- Company News: Merck (MRK) quarterly earnings beat analysts’ expectations
Market news
1 February 2019
Company News: Merck (MRK) quarterly earnings beat analysts’ expectations
Merck (MRK) reported Q4 FY 2018 earnings of $1.04 per share (versus $0.98 in Q4 FY 2017), beating analysts’ consensus estimate of $1.03.
The company’s quarterly revenues amounted to $10.988 bln (+5.4% y/y), generally in line with analysts’ consensus estimate of $10.929 bln.
The company also issued in-line guidance for FY 2019, projecting EPS of $4.57-4.72 (versus analysts’ consensus estimate of $4.70) and revenues of $43.2-44.7 bln (versus analysts’ consensus estimate of $44.42 bln).
MRK rose to $75.45 (+1.37%) in pre-market trading.
Market Focus
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerOpen Demo Account & Personal Page